Four decades of HIV/AIDS - much accomplished, much to do

Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)

Barré-Sinoussi, F., Chermann, J. C., Rey, F., Nugeyre, M. T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vézinet-Brun, F., Rouzioux, C., et al. (1983) · Science · doi:10.1126/science.6189183 · Cited by 7,038

Prevention of HIV-1 infection with early antiretroviral therapy.

Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Grinsztejn, B., Pilotto, J. H. S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105243 · Cited by 6,873

Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS

Gallo, R. C., Salahuddin, S. Z., Popovič, M., Shearer, G. M., Kaplan, M., Haynes, B. F., Palker, T. J., Redfield, R. R., Oleske, J. M., Safai, B., et al. (1984) · Science · doi:10.1126/science.6200936 · Cited by 3,639

Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy

Gulick, R. M., Mellors, J. W., Havlir, D. V., Eron, J. J., Gonzalez, C. J., McMahon, D. K., Richman, D. D., Valentine, F. T., Jonas, L., Meibohm, A. R., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709113371102 · Cited by 1,883

An Outbreak of Community-AcquiredPneumocystis cariniiPneumonia

Masur, H., Michelis, M. A., Greene, J. B., Onorato, I. M., Stouwe, R. A. V., Holzman, R. S., Wormser, G. P., Brettman, L. R., Lange, M., Murray, H. W., et al. (1981) · New England Journal of Medicine · doi:10.1056/nejm198112103052402 · Cited by 1,434

5-Cyano substituted diarylpyridines as potent HIV-1 NNRTIs: Rational design, synthesis, and activity evaluation

Song, H., Xia, Y., Zhang, T., Dun, C., Meng, B., Clercq, E. D., Pannecouque, C. C., Kang, D., Zhan, P., & Liu, X. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115686 · Cited by 4

Environmental change and infectious diseases in the Mediterranean region and the world: an interpretive dialectical analysis

Friedman, S. R. (2020) · Euro-Mediterranean Journal for Environmental Integration · doi:10.1007/s41207-020-00212-9 · Cited by 4

Self-Disclosure as a Public Health Intervention

Johnson, M. C. (2021) · Academic Psychiatry · doi:10.1007/s40596-021-01476-1 · Cited by 4

Chronic Pain, Mental Health, and Sense of Purpose in Life Among Women Living with HIV Compared to HIV-Negative Women in the British Columbia CARMA-CHIWOS Collaboration (BCC3) Study

Ragazan, D. C., Povshedna, T., Tognazzini, S., Kaida, A., Murray, M. C. M., & Côté, H. C. F. (2025) · AIDS and Behavior · doi:10.1007/s10461-025-04644-8 · Cited by 3

Machine learning-based prediction of mortality risk in AIDS patients with comorbid common AIDS-related diseases or symptoms

Chen, Y., Pan, K., Lu, X., Maimaiti, E., & Wubuli, M. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1544351 · Cited by 3

The safety of cabotegravir in pregnancy: a systematic review and meta-analysis

Jasper, A., Fourie, W., & Chetty, S. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-11817-2 · Cited by 3

Anticholinergic burden interacts with age and AIDS history to amplify frailty in people with HIV

Mazzitelli, M., Trunfio, M., Leoni, D., Sasset, L., Barbison, L., Favaro, A., Gardin, S., Farina, J., Scaglione, V., Sergi, G., et al. (2026) · British Journal of Clinical Pharmacology · doi:10.1002/bcp.70504 · Cited by 3

Structure-based discovery of novel diarylpyrimidines as potent and selective Non-Nucleoside reverse transcriptase inhibitors: From CH(CN)-Biphenyl-Diarylpyrimidines to C NNH2-Biphenyl-Diarylpyrimidines

Chen, X., Pannecouque, C. C., Clercq, E. D., Lian, Y.-X., Corona, A., Dettori, L., Tramontano, E., Wang, S., & Chen, F. E. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117271 · Cited by 3

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Mbayo, V., Govender, P. P., Marondedze, E. F., & Govender, K. K. (2025) · Journal of Visualized Experiments · doi:10.3791/67457 · Cited by 3

Discovery of novel diarypyrimidine derivatives as potent HIV-1 NNRTIs by exploiting the tolerant region I within NNRTI binding pocket

Ji, X., Jiang, X., Gao, Z., Gao, H., Clercq, E. D., Pannecouque, C. C., Kang, D., Zhan, P., & Liu, X. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117787 · Cited by 3

HIV Testing Autonomy: The Importance of Relationship Factors in HIV Testing to People in Lusaka and Chongwe, Zambia

Kasoka, K., & Weait, M. J. (2022) · Journal of Bioethical Inquiry · doi:10.1007/s11673-022-10169-9 · Cited by 4

Identification of Novel Diarylpyrimidines as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors by Exploring the Primer Grip Region

Zhang, T., Zhou, Z., Zhao, F., Sang, Z., Clercq, E. D., Pannecouque, C. C., Kang, D., Zhan, P., & Liu, X. (2022) · Pharmaceuticals · doi:10.3390/ph15111438 · Cited by 3

Leveraging mHealth and Patient Supporters for African Americans' and Latinxs' Engagement in HIV Care (LEAN): Protocol for a Randomized, Controlled, Effectiveness-Implementation Trial

Jones, J. L., McKenzie‐White, J., Saxton, R. E., Grieb, S. M. D., Nonyane, B. A. S., Graham, C., Cano, A., Johnson, S. M., Childs, L., Greenbaum, A. H., et al. (2022) · JMIR Research Protocols · doi:10.2196/42691 · Cited by 3

Viral agents (2nd section)

(2024) · Transfusion · doi:10.1111/trf.17630 · Cited by 3

Human immunodeficiency virus infection challenges: Current therapeutic limitations and strategies for improved management through long‐acting injectable formulation

Tanushree, T., Sharma, A., Monika, Singh, R. P., & Jhawat, V. (2024) · Reviews in Medical Virology · doi:10.1002/rmv.2563 · Cited by 3

Antiviral Drug Discovery

Zhou, Z., Liu, X., & Kang, D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137413 · Cited by 3

The Flip Side of the Coin: Potential Hazards Associated with Standardization in Healthcare

Fuller, H. J. A., & Arnold, T. (2021) · Lecture notes in networks and systems · doi:10.1007/978-3-030-80744-3_9 · Cited by 3

First Cousin Once Removed

Farrell, M. J. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.22.02611 · Cited by 3

Anti-HIV and Anti-Candidal Effects of Methanolic Extract from Heteropterys brachiata

Huerta‐Reyes, M., Sánchez-Vargas, L. O., Villanueva-Amador, G. S., & Gaitán-Cepeda, L. A. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18147270 · Cited by 4

Achieving the cancer moonshot in Africa

Adewole, I. F., Kobayashi, E., O’Brien, M., Orem, J., Rositch, A. F., & Ngwa, W. F. (2022) · ecancermedicalscience · doi:10.3332/ecancer.2022.ed126 · Cited by 3

Assessment of Metabolic, Inflammatory, and Immunological Disorders Using a New Panel of Plasma Parameters in People Living with HIV Undergoing Antiretroviral Therapy—A Retrospective Study

Szymańska, B., Knysz, B., Ciepłucha, H. D., & Piwowar, A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13154580 · Cited by 2

Exploring the HIV-1 Reverse Transcriptase p51/p66 Interface: Structure-Based Design and Optimization of Novel 2,4,6-Trisubstituted Pyrimidines as Potent NNRTIs with Improved Resistance Profiles

Ji, X., Jiang, X., Gao, Z., Gao, H., Huang, X., Zhao, F., Clercq, E. D., Wang, Z., Pannecouque, C. C., Kang, D., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c01695 · Cited by 2

Association of dietary patterns with anxiety and depression symptoms in people living with HIV: a population-based cross-sectional study from China

Nie, Z., Tang, H., Liu, Y., Zhu, K., Wu, C., Cheng, J., Zhang, M., Wang, F., & Han, S. (2025) · BMC Public Health · doi:10.1186/s12889-025-25475-1 · Cited by 2

Antiviral Strategies in the Treatment of Human and Animal Viral Infections

Parikesit, A. A. (2023) · Infectious diseases · doi:10.5772/intechopen.111006 · Cited by 2

Determinants of an HIV Preventive Vaccine among a Highly Vulnerable Population: African American Men Who Have Sex with Men

Xu, M. A., Choi, J., Rosenberger, J. G., Zimmerman, R. S., & DiClemente, R. J. (2024) · Vaccines · doi:10.3390/vaccines12030323 · Cited by 2

Preparing for future pandemics while responding to the current ones in the midst of a planetary climate crisis: Can we face this triple global health challenge?

Ferraz, D., & Barreira, D. (2024) · Global Public Health · doi:10.1080/17441692.2024.2351593 · Cited by 2

Characterizing treatment interruptions in the OPERA cohort and virologic outcomes after resumption with bictegravir/emtricitabine/tenofovir alafenamide

Mounzer, K., Osterman, M. D., Brunet, L., Hsu, R. K., Pierone, G., Fusco, J. S., Menezes, N. P., Gruber, J., Lim, T. W., Dunbar, M. S., et al. (2025) · AIDS Research and Therapy · doi:10.1186/s12981-025-00769-x · Cited by 2

Importancia de los estudios de anatomía patológica en COVID-19

Toscano, A. Á., Bassols, Á. C., & González, J. J. E. (2020) · Medicina Crítica · doi:10.35366/94901 · Cited by 2

Pandemic Responses and the Strengths of Health Systems: A Review of Global AIDS Historiography in Light of COVID-19

Kanazawa, R. (2023) · Isis · doi:10.1086/726985 · Cited by 2

A Half-Century of Progress in Health — A Perspective Series in Honor of the 50th Anniversary of the National Academy of Medicine

Dzau, V. J., Fineberg, H. V., Shine, K. I., Thier, S. O., Malina, D., & Morrissey, S. (2020) · New England Journal of Medicine · doi:10.1056/nejme2020118 · Cited by 2

The Prevalence of HLA-B*57 Serotype Associated with Hypersensitivity Reactions in the Treatment of HIV İnfection in the Turkish Population

Kızmaz, M. A., Şimşek, A., Aymak, F., Akalın, H., Oral, H. B., & Budak, F. (2023) · Current HIV Research · doi:10.2174/1570162x21666230731145350 · Cited by 1

Structure‐based design, synthesis, and biological characterization of indolylarylsulfone derivatives as novel human immunodeficiency virus type 1 inhibitors with potent antiviral activities and favorable drug‐like profiles

Wang, Z., Wang, W., Gao, Z., Gao, H., Clercq, E. D., Pannecouque, C. C., Chen, C., Kang, D., Zhan, P., & Liu, X. (2024) · Journal of Medical Virology · doi:10.1002/jmv.29830 · Cited by 1

19 Understanding and Reporting the Natural History of an Infectious Disease

Crozier, I. (2024) · Springer eBooks · doi:10.1007/978-3-031-48408-7_28 · Cited by 1

Unveiling neuroimmunology profile of immunological non-responders in HIV: a multimodal MRI approach

Zhang, Y., Ji, J., Zheng, L., Cai, M., Sun, G., Ma, Y., Zhang, X., Chen, X., Zhang, Y., Lin, X., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1452532 · Cited by 1

Dihydroartemisinin Inhibits T Cell Activation in People Living with HIV with Incomplete Immune Reconstitution In Vitro

Zhang, Y., Ji, J., Dou, X., Wang, R., Wu, H., Li, Z., & Zhang, T. (2024) · Journal of Exploratory Research in Pharmacology · doi:10.14218/jerp.2024.00014 · Cited by 1

Reluctance of people living with HIV in Malaysia to disclose status in dental settings: a cross-sectional study

Mohamed, N., Saddki, N., Yusoff, A. M., Rahman, N. A., Hashim, H., & Jelani, A. M. (2025) · Journal of HIV & Social Services · doi:10.1080/15381501.2025.2481398 · Cited by 1

Acceptability of broadly neutralizing antibodies (bNAbs) for HIV prevention among vulnerable populations in India: Findings from a qualitative study

Mukherjee, J., Hadi, S. U., Chakrapani, V., Rawat, S. M., Srikrishnan, A. K., Mahendra, V. S., Baruah, D., Mohapatra, S., Gopinath, U., Dange, A., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0321725 · Cited by 1

Impact of Dolutegravir-based regimens on patient satisfaction and quality of life among people living with HIV: A systematic review and meta-analysis protocol

Abubakar, M. M., Ifeorah, I. K., Bello, A. M., Isah, A., Jeminiwa, R. N., Joel, S. U., Uboh, K. H., Iremeka, H. C., Nwachuya, C., Musa, S., et al. (2025) · Journal of Interventional Epidemiology and Public Health · doi:10.37432/jieph-d-25-00099 · Cited by 1

Prevalence of potentially inappropriate medications in people living with HIV: a systematic review and meta-analysis

Abubakar, M. M., Isah, A., Jeminiwa, R. N., Abioye, I., Yunusa, I. U., Abba‐Aji, M., Cole, O. K., Sani, J., Ijaiya, M., Nwachuya, C. A., et al. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-11996-y · Cited by 1

Characterizing AIDS Drug Assistance Program Practices and Policies for Sustained Viral Suppression Using the Consolidated Framework for Implementation Research: Protocol for a Qualitative Study

McManus, K. A., Rogers, E. Q., Steen, A., Killelea, A., Horn, T. H., Panagides, R., Laymon, S. E., & Keim‐Malpass, J. (2026) · JMIR Research Protocols · doi:10.2196/90008 · Cited by 1

Virologic, immunologic, and metabolic outcomes and mortality in people with HIV on bictegravir/emtricitabine/tenofovir alafenamide fumarate versus dolutegravir-based antiretroviral therapies: a retrospective multicenter cohort study in China

Wu, X., Ma, P., Ruan, L., Chen, Y., Wang, R., Song, Y., Cai, Y., Chen, F., Zhang, L., Fitzpatrick, T., et al. (2026) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2026.101835 · Cited by 1

The HIV/AIDS Epidemiological Challenges: Why is HIV Incidence Rising While AIDS Incidence and Mortality are Declining in Brazil?

Lopes‐Araujo, H. F., Guedes, M. C. S., Carvalho‐Silva, W. H. V., & Guimarães, R. L. (2026) · Journal of Community Health · doi:10.1007/s10900-026-01590-x · Cited by 1

Effect of aging on immune cells in male HIV-infected and -uninfected healthy individuals

Rai, M. A., Shi, V., Kennedy, B. D., Whitehead, E. J., Justement, J. S., Paul, S., Blažková, J., & Chun, T. (2022) · AIDS · doi:10.1097/qad.0000000000003331 · Cited by 1

UK media responses to HIV through the lens of COVID-19: a study of multidirectional memory

Pheasant‐Kelly, F. (2023) · Medical Humanities · doi:10.1136/medhum-2022-012575 · Cited by 1

Stigma Pada Penderita HIV/AIDS: A Systematic Review

Heru, M. J. A., Jatimi, A., & Hidayat, M. (2024) · Indonesian Health Science Journal · doi:10.52298/ihsj.v3i2.43 · Cited by 1

Leveraging Machine Learning Models to Predict HIV/AIDS Treatment Interruption in Patients in Machakos County, Kenya

Odundo, C., Katila, C., Njuki, S., Onyango, L., & Makori, F. (2025) · International Journal of Data Science and Analysis · doi:10.11648/j.ijdsa.20251106.11 · Cited by 1

Corrigendum to: Lesbian, Gay, Bisexual, Transgender, and Queer (LGBTQ+) Communities and the Coronavirus Disease 2019 Pandemic: A Call to Break the Cycle of Structural Barriers

Gil, R. M., Freeman, T. L., Mathew, T. A., Kullar, R., Fekete, T., Ovalle, A. A., Nguyen, D., Kottkamp, A. C., Poon, J., Marcelin, J. R., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab408 · Cited by 1

Scientific hubris and a squeamish necropolitics: tracing continuities and discontinuities in AIDS discourses from the perspective of COVID-19

Tucker, A., & Kearns, G. (2022) · Social & Cultural Geography · doi:10.1080/14649365.2022.2130418 · Cited by 1

Remarkable Advances in Clinical Medicine that Have Occurred Since I Was an Intern

Alpert, J. S. (2023) · The American Journal of Medicine · doi:10.1016/j.amjmed.2023.01.003 · Cited by 1

Pandemic Planning

Ball, R. T., John, J. F., & Schmidt, M. G. (2024) · doi:10.1002/9781683673941.ch52 · Cited by 1

The human plasma amino acids balance favours HIV replication in primary CD4 T lymphocytesPreprint

Chauveau, L., Fortuin, A., Lecante, A., Lager-Lachaud, N., Tellier, A., Honne, S., Boulay, A., Blanchet, F. P., Kim, B., Bellvert, F., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.10.627699 · Cited by 1

Introduction to Special Issue on ‘Statistical Methods for HIV/AIDS Research’

Chen, Y. Q. (2020) · Statistics in Biosciences · doi:10.1007/s12561-020-09296-x

The Immunomodulatory Effects of Artesunate on Immunological Non-Responders in Long-Term ART-Treated People Living with HIV: A Multicenter and Prospective StudyPreprint

Tao, Z., Ma, C., Dong, J., Guo, H., Li, X., Tan, X., Yang, Y., Ma, J., Liu, S., Wang, J., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3990867

Editorial of Special Column on Antiviral Drug Discovery and Pharmacology

Wang, J., & Li, H. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.03.005

Law, Criminalization and HIV in the World: Have Countries That Criminalize Achieved More or Less Successful Pandemic Response?Preprint

Kavanagh, M. M., Agbla, S. C., Joy, M., Aneja, K., Pillinger, M., Case, A., Erondu, N. A., Erkkola, T., & Graeden, E. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3925649

The LEAN (LEveraging mHealth and patient supporters for African-Americans and Latinxs eNgagement in HIV care) Trial: study protocol for a randomized, controlled, effectiveness-implementation trial (Preprint)Preprint

Jones, J. L., McKenzie‐White, J., Saxton, R. E., Grieb, S. M. D., Nonyane, B. A. S., Graham, C., Cano, A., Johnson, S. M., Childs, L., Greenbaum, A. H., et al. (2022) · doi:10.2196/preprints.42691

Noncommunicable diseases and conditions

Tulchinsky, T. H., Varavikova, E. A., & Cohen, M. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-822957-6.00014-4

Stigma Kills

Salvaña, E. M. T. (2023) · Acta Medica Philippina · doi:10.47895/amp.v57i4.7864

Mechanical circulatory support in HIV+ patients: Science wins but bias remains

Madan, S., Hemmige, V. S., & Jorde, U. P. (2023) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2023.05.013

In Situ Click Chemistry-Based Discovery of 1,2,3-Triazole-Derived Diarylpyrimidines as Novel HIV-1 NNRTIS by Exploiting the Tolerant Region I in Binding PocketPreprint

Sun, Y., Feng, D., Zhou, Z., Zhang, T., Clercq, E. D., Pannecouque, C. C., Kang, D., Zhan, P., & Liu, X. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4565706

Antiviral Targets and Known Antivirals (HAART)

Ifedilichukwu, N. H., & Oladimeji-Salami, J. A. (2023) · Infectious diseases · doi:10.5772/intechopen.112551

AIDS: Treatment Strategies for AIDS Patients

(2023) · International Journal of Agriculture and Biosciences · doi:10.47278/book.zoon/2023.129

Provider perspectives on healthcare provision via telemedicine to persons with HIV living in an urban community

Grewal, R., Jones, R. E., Webb, F. J., Webster-Bass, S., Peters, J., Smotherman, C. R., & Gelaude, D. (2024) · Health Policy and Technology · doi:10.1016/j.hlpt.2024.100853

“Double wahala for dead body”: Adherence to Antiretroviral Therapy among Persons with Disabilities Living with Human Immunodeficiency Virus in Nigeria

Philip, A. A. (2024) · Queensland University of Technology · doi:10.5204/thesis.eprints.246681

Criminalization of Human Immunodeficiency Virus in the United States

Lennon-Dearing, R. (2024) · Nursing Clinics of North America · doi:10.1016/j.cnur.2024.01.001

Severe Cholestatic Hepatitis in Retroviral Infection

Ravi Shankar Bagepally, B. (2024) · International Journal of Science and Research (IJSR) · doi:10.21275/sr24427112930

Human immunodeficiency virus/acquired immunodeficiency syndrome in the infant

Shetty, A. K., & Maldonado, Y. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-79525-8.00032-9

Developing a Theory-Based Instrument for Pre-Exposure Prophylaxis (PrEP) Uptake in People of Color Using a Qualitative Approach

Raich, S., Johansen, C. M., Bhandari, N., Batra, K., & Sharma, M. (2024) · Healthcare · doi:10.3390/healthcare12161595

Prognostic prediction models for treatment experienced people living with HIV: a protocol for systematic review and meta-analysis

Wu, X., Chen, Y., Lu, Z. Z., Wang, J., & Zou, H. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-081129

Reducing Cardiovascular Risk in HIV: The Unseen Impact of Visceral Fat

Roberts, E. (2024) · Microbiology & infectious diseases : · doi:10.33590/microbiolinfectdisam/ezsw5271

PEPFAR Funding Saves Lives and Money

Assoumou, S. A., & Vahey, S. (2025) · Annals of Internal Medicine · doi:10.7326/annals-25-00455

Ending the TB epidemic – what can we learn from the HIV epidemic?

Harries, A. D. (2025) · IJTLD OPEN · doi:10.5588/ijtldopen.24.0618

Impact of HIV Infection on Hepatocellular Carcinoma: A Long-Term Prognostic Analysis

Diao, Y.-H., Gong, F., & Cheng, Y. (2025) · Journal of Laparoendoscopic & Advanced Surgical Techniques · doi:10.1089/lap.2024.0191

Risk Factors Among HIV Seropositive Cases Attending a Tertiary Care Hospital of a North-Eastern State of India: A Hospital-Based Retrospective Cross-Sectional Study

Raja, D., Nath, H., Engtipi, R., Medhi, D., Daimari, D., & Mahanta, P. (2025) · Cureus · doi:10.7759/cureus.80455

Polyneuropathies and Mononeuropathies Multiplex

Kimura, J., & Strakowski, J. A. (2025) · Oxford University Press eBooks · doi:10.1093/med/9780197658017.003.0024

Application of Extreme Gradient Boosting to predict NCD-HIV/AIDS comorbidity in young adults in MalawiPreprint

Kasambara, A., Kamndaya, M. S., Masangwi, S. J., & Mulaga, A. N. (2025) · medRxiv · doi:10.1101/2025.08.05.25333013 · Cited by 1

T-shaped alignments integrating HIV-1 near full-length genome and partial pol sequences can improve phylogenetic inference of transmission clusters

Guang, A., Dunn, C. W., Novitsky, V., Howison, M., & Kantor, R. (2025) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1013676

Additional file 3 of Vpr driving DNA methylation variation of CD4 + T cells in HIV-1 infection

Wang, P., Meng, Z., Deng, K., Gao, Z., & Cai, J. (2024) · Figshare · doi:10.6084/m9.figshare.26713004

Additional file 2 of Vpr driving DNA methylation variation of CD4 + T cells in HIV-1 infection

Wang, P., Meng, Z., Deng, K., Gao, Z., & Cai, J. (2024) · Figshare · doi:10.6084/m9.figshare.26713001

Additional file 1 of Vpr driving DNA methylation variation of CD4 + T cells in HIV-1 infection

Wang, P., Meng, Z., Deng, K., Gao, Z., & Cai, J. (2024) · Figshare · doi:10.6084/m9.figshare.25706131

Building Successful Career Trajectories for Early-Stage Investigators in HIV Research: Reflections from the DC CFAR My Path to Independence Series

Bukrinsky, M., Segarra, L., Alexander, A., & Rakhmanina, N. Y. (2026) · AIDS Research and Human Retroviruses · doi:10.1177/08892229261426066

Healthcare Resource Consumption and Related Costs of People Living with HIV and Antiviral Treatment: A Retrospective Observational Study in Italy

Esposti, L. D., Mazzoni, S., Cappuccilli, M. L., Maggiolo, F., Caputo, S. L., Nozza, S., Taramasso, L., Marra, A., & Pittorru, M. (2026) · Diseases · doi:10.3390/diseases14030110

From lab to clinic: The evolution of reverse transcriptase inhibitors in HIV treatment

Nie, M.-Z., Gu, S.-X., Chen, J. J., Guo, J., Cai, L., & Zhu, Y.-Y. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-36518-8.00008-4

Food insecurity and cardiometabolic diseases among people with HIV in West Africa

Benzekri, N. A., Plaisy, M. K., Koffi, J. J., Mensah, E., Minga, A., Ekouévi, D. K., Moh, R., & Jaquet, A. (2026) · AIDS · doi:10.1097/qad.0000000000004541

Divergent Burden Profiles of HIV/AIDS and Other Sexually Transmitted Infections Among Women of Child-Bearing Age, 1990–2021

Li, Z., Li, S., Lin, G., Zou, Y., & You, C. (2026) · International Journal of Women s Health · doi:10.2147/ijwh.s608337

Comparison Of Clinical Stadium Changes And Immunologic Parameter Of Adult HIV patients With Dolutegravir And Efavirenz Based Antiretroviral Therapy

Zuhdi, M. N., Halim, R., Alimuddin, S., Bakri, S., Iskandar, H., & Zainuddin, A. (2026) · F1000Research · doi:10.12688/f1000research.179310.1 · Cited by 1

The prevalence of anxiety disorders among people living with HIV in India: A systematic review and meta-analysis

Debnath, A., Achary, T., Mondal, A., Halder, P., Tom, A., Saha, S., & Purkait, A. T. (2026) · Indian Journal of Psychiatry · doi:10.4103/indianjpsychiatry_150_26

Metabolic and Immunological Trajectories and Virological Outcomes of Ainuovirine‐Based Antiretroviral Therapy: A 48‐Week Longitudinal Cohort Study in Treatment‐Naïve Adults

Gan, L., Xie, X., Fu, Y., Yang, X., Ma, S., Song, C., Song, Y., Ren, T., & Long, H. (2026) · Journal of Medical Virology · doi:10.1002/jmv.71038

Rational design of dual-site NNRTIs based on 2,4,5-trisubstituted pyrimidine scaffold for potent inhibition of resistant HIV-1

Ji, X., Jiang, X., Gao, H., Clercq, E. D., Pannecouque, C. C., Kang, D., Zhan, P., & Liu, X. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.119193

Knowledge, Culture, and Communication in HIV Prevention: A Mixed-Methods Study of Nurse Practitioners’ Roles in Pre-exposure Prophylaxis (PrEP) Uptake in Rural and Underserved Areas

Gant, J. E., Miller, J. S., & Franklin, E. G. (2026) · AIDS Education and Prevention · doi:10.1521/aeap.2026.38.4.335

Fc-engineered broadly neutralizing antibodies overcome cytokine-induced CD16 cleavage to drive potent ADCC against diverse HIV-1 strains

Melo, C., Murphy, T. A., Holmberg, C. S., Kelly, M., McMahon, E. K., Lochner, J. S., Lynch, R. M., & Bosque, A. (2026) · mBio · doi:10.1128/mbio.01724-26

Examining our ABC’s: Attention, blindspots and constructions in HIV and AIDS scholarship

Evans, M. D. (2026) · Administrative Theory & Praxis · doi:10.1080/10841806.2026.2700801

Screening of epigenetic modifiers identifies novel host-directed agents that suppress HIV-1 replication in primary human macrophagesPreprint

Lê-Bury, G., Mandalasi, C., Rhen, J. M., Gludish, D. W., Boliar, S., Mwandumba, H. C., & Russell, D. G. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.01.748500

Evaluation of The Effectiveness of Hiv Prevention Programs in Russian

Kravchenko, A. F., & Chereshova, S. V. (2026) · University Management Practice and Analysis · doi:10.15826/umpa.2026.02.005

Targeting the HIV-1 NNRTI Entrance Channel: Structure-Guided Optimization for Enhanced Safety and Selectivity

Zhang, Y., Dong, L., Niu, Y.-T., Lei, Z.-Z., Xu, Q., Zhao, L., Deng, H., Pannecouque, C. C., Clercq, E. D., Tran, P., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c02358

Life expectancy among women and men with HIV after achieving sustained virologic suppression in the Bronx, New York: a clinical cohort study

Peters, B. A., Fazzari, M. J., Felsen, U. R., Jones, H. E., Ginsberg, M. S., Hanna, D. B., & Anastos, K. (2026) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2026.101668

BindingDB Entry 50016869: Contemporary Medicinal Chemistry Strategies for the Discovery and Development of Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors.

BindingDB (2023) · UC San Diego · doi:10.7270/q2sn0f0p

BindingDB Entry 50018563: Lead Optimization and Avoidance of Metabolic-perturbing Motif Developing Novel Diarylpyrimidines as Potent HIV-1 NNRTIs.

BindingDB (2024) · UC San Diego · doi:10.7270/q2nv9pg3

BindingDB Entry 50019540: Escaping from Flatland: Multiparameter Optimization Leads to the Discovery of Novel Tetrahydropyrido[4,3-

BindingDB (2024) · UC San Diego · doi:10.7270/q2v1295f

BindingDB Entry 50022346: 5-Cyano substituted diarylpyridines as potent HIV-1 NNRTIs: Rational design, synthesis, and activity evaluation.

BindingDB (2025) · UC San Diego · doi:10.7270/q21c22mc

Editorial: Fast-tracking HIV prevention: scientific advances and implementation challenges

Govender, K., & Poku, N. K. (2016) · African Journal of AIDS Research

Accomplishments in HIV prevention science: implications for stemming the epidemic

Valdiserri, R. O., Ogden, L. L., & McCray, E. (2003) · Nature Medicine · doi:10.1038/nm0703-881 · Cited by 66

Fast-tracking HIV prevention: scientific advances and implementation challenges

Govender, K., & Poku, N. K. (2016) · African Journal of AIDS Research · doi:10.2989/16085906.2016.1208944 · Cited by 2

HIV/AIDS in the Fourth Decade

Mugavero, M. J., & Kilby, J. M. (2017) · doi:10.1093/med/9780199392742.003.0002

The Best of Times and the Worst of Times: Implications of Scientific Advances in HIV Prevention for Women in the Developing World

Gupta, G. R. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05468.x · Cited by 2